GraftJacket Versus Tendon Interposition for Trapeziometacarpal Osteoarthritis
NCT ID: NCT01724840
Last Updated: 2016-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2012-09-30
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Suture Fixation System Versus Tendonous Reconstruction in Carpometacarpal (CMC) Arthroplasty
NCT01121874
LRTI vs Internal Brace for CMC OA
NCT03971188
Anatomic TSA Vs RTSA for Glenohumeral Arthritis
NCT04629391
Comparison Between Hemitrapeziectomy and Total Trapeziectomy With Ligament Reconstruction and Tendon Interposition in Trapeziometacarpal Osteoarthritis II-III Eaton-Littler
NCT02693600
Comparison of Two Resurfacing Prostheses in the Treatment of Osteoarthritis of the Shoulder
NCT00408096
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Another option is using allograft, which is dermal or tendon tissue from another human donor such as the GraftJacket (Wright Medical Technology, Inc., Arlington, TN). This product is manufactured from donated cadaveric tissue that is treated to remove all cellular components while preserving the native collagen scaffold. It thus provides the strength and integrity of native autograft without the adverse immunologic response of traditional allograft. It is in compliance with the American Association of Tissue Banks guidelines for allograft material, and it is classified as human tissue for transplantation.
The GraftJacket shows high biocompatibility and the advantages compared to autograft are avoiding donor site morbidity as well as decreased surgical time.
GraftJacket has mainly being used for the repair of rotator cuff tears and Achilles tendons ruptures. No complications have been reported and patients showed significant improved outcomes compared with their preoperative conditions. Although all of the studies show methodological limitations due to the lack of a control group, these results show a great potential and warrant further investigations.
In contrast to the studies already conducted in the Achilles tendon and shoulder joint, there are only sparse data concerning other joints of the upper extremity such as the elbow and the hand. Treating TMC OA of Eaton stage ll, lll and lV with GraftJacket has only been reported in two studies. The patients under investigation reported significant pain relief, significant improvements regarding grip and key pinch strength, good ability to perform activities of daily living (ADL) and high satisfaction rates. No or only minimal postoperative complications such as paraesthesia which are not directly related to the GraftJacket have been reported. However, some limitations of these two studies have to be acknowledges. Both are observational studies without control group making it impossible to conclude if this approach is favourable compared to standard techniques.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GraftJacket
GraftJAcket is used as interpositional material
GraftJacket
Interposition with GraftJacket
Tendon Interposition
Flexor carpi radialis tendon is used as interpositional material
Tendon Interposition
Tendon Interposition with the FCR tendon
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GraftJacket
Interposition with GraftJacket
Tendon Interposition
Tendon Interposition with the FCR tendon
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* willing to participate and provide informed consent
Exclusion Criteria
* pregnant women,
* legal incompetent patients,
* persons with insufficient knowledge of the German language to complete the questionnaires
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Schulthess Klinik
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daniel Herren
MD, MHA
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel B Herren, MD, MHA
Role: PRINCIPAL_INVESTIGATOR
Schulthess Klinik
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Schulthess Klinik
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GraftJacket01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.